Lineage Cell Therapeutics
LCTX
LCTX
115 hedge funds and large institutions have $105M invested in Lineage Cell Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 13 closing their positions.
Holders
115
Holders Change
+9
Holders Change %
+8.49%
% of All Funds
1.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
26
Reduced
21
Closed
13
Calls
$121K
Puts
$4K
Net Calls
+$117K
Net Calls Change
+$38K